AMOEBA (EPA:ALMIB) | Finanzwire

PRESS RELEASE

published on 10/03/2024 at 17:45, 1 year 3 months ago

Amoéba: the first half of 2024 confirms the strategic pivot towards an industrial and commercial company from 2025 onwards
Amoéba reports strategic shift to commercial focus & positive operating income growth in H1 2024. Financial outlook secured until mid-2025. Development plans for biocontrol & cosmetics segments

AMOEBA Financial Results Biocontrol Cosmetics Strategic Shift
BRIEF

published on 10/02/2024 at 17:50, 1 year 3 months ago

AMOEBA: Total number of voting rights and shares as of September 30, 2024

AMOEBA Voting Rights Capital Actions Financial Markets
BRIEF

published on 08/28/2024 at 17:50, 1 year 5 months ago

Amoéba Prepares for US Launch of AXPERA Product Line by 2025

Market Authorization 2025 Targets AXPERA Launch EPA Approval Biocontrol Products
PRESS RELEASE

published on 08/28/2024 at 17:45, 1 year 5 months ago

AMOEBA prepares for the commercial launch of the AXPERA Product Line in the USA with approval expected by 2025
Amoéba's biofungicide products receive US EPA's admissibility confirmation for registration dossier, accelerating industrial and commercial development. Application for market authorization has been submitted. Collaboration with Dunham Trimmer in progress

AMOEBA Collaboration Market Authorization Biofungicide US EPA
BRIEF

published on 07/02/2024 at 08:35, 1 year 6 months ago

AMOEBA: A NEW LEGAL STRUCTURE TO MAXIMISE COMMERCIAL ACTIVITIES

AMOEBA Biocontrol Cosmetics Legal Reorganisation Subsidiary
REGULATED PRESS RELEASE

published on 07/02/2024 at 08:30, 1 year 6 months ago

AMOEBA: A NEW LEGAL STRUCTURE TO MAXIMISE COMMERCIAL ACTIVITIES
Amoéba announces a reorganisation to enhance commercial activities in biocontrol and cosmetics sectors, aiming to create value for shareholders. New legal structure to optimize resources and facilitate partnerships

AMOEBA Biocontrol Cosmetics Legal Structure Commercial Activities
BRIEF

published on 06/21/2024 at 13:41, 1 year 7 months ago

Edison Issues Report on Amoéba (ALMIB)

AMOEBA Financial Report Edison Investment Research ALMIB
PRESS RELEASE

published on 06/21/2024 at 13:36, 1 year 7 months ago

Edison issues report on Amoéba (ALMIB)
Edison Investment Research Limited issues report on Amoéba (ALMIB) available for download. Not a solicitation to buy or sell securities

AMOEBA Edison Investment Research Limited Financial Analysis Report ALMIB
BRIEF

published on 06/10/2024 at 17:50, 1 year 7 months ago

AMOÉBA Confirms Development Potential in Cosmetics Sector

AMOEBA Clinical Study Cosmetics Skincare INCI List
REGULATED PRESS RELEASE

published on 06/10/2024 at 17:45, 1 year 7 months ago

CONFIRMATION OF THE DEVELOPMENT POTENTIAL OF AMOEBA IN COSMETICS
Amoéba's clinical study confirms the development potential of its cosmetic ingredient for skincare products. Management to present strategy at annual conference in Paris

AMOEBA Clinical Study Cosmetics Paris Conference Skincare Products

Published on 01/30/2026 at 14:00, 2 hours 15 minutes ago

CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 7 hours 40 minutes ago

Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 8 hours 15 minutes ago

Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 14 hours ago

Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 16 hours 15 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies

View all ACCESSWIRE

Published on 01/30/2026 at 16:00, 15 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Dauch Corporation
Published on 01/30/2026 at 15:59, 15 minutes ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 01/30/2026 at 15:58, 16 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Glencore plc
Published on 01/30/2026 at 15:57, 17 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/30/2026 at 15:56, 18 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc

View all EQS

Published on 01/30/2026 at 08:00, 8 hours 15 minutes ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 22 hours 15 minutes ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 22 hours 30 minutes ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 22 hours 30 minutes ago

Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 17:40, 22 hours 35 minutes ago

ALTEN: Annual revenue 2025

View all LES ECHOS COMFI WIRE

News